• About us
• Contact

Advertisement

Organisation › Details

PMOD Technologies LLC (CH)

PMOD Technologies aims to equip researchers with best-in-class software tools for biomedical imaging research in humans and animals. The PMOD suite of software tools is a comprehensive platform for quantitative imaging and is a leading solution for PET kinetic modelling and parametric mapping. PMOD software includes solutions for image registration, automated volume-of-interest definition in neurology, oncology and cardiology, radiomics feature extraction, 3D image visualization and computational fluid dynamics (CFD) modelling. PMOD has an expanding customer base of more than 600 sites, with an estimated 2,000 active users worldwide. Interactive and responsive collaborations with leading imaging research institutions ensure that methodology and scope of the PMOD software remain at the leading edge. *

 

	Start	2003-08-21 established (s-off)
	Group	Bruker (Group)
	Industry	PMOD software (for PET molecular imaging analysis)
	Industry 2	molecular imaging
	Person	Burger, Cyrill (PMOD Technologies 201907 CEO)
	Region	Zürich ZH
	Country	Switzerland
	Street	25 Sumatrastr.
	City	8006 Zürich ZH
	Tel	+41-44-350-4600
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«:
		Record changed: 2026-04-25

Advertisement

More documents for Bruker (Group)

• [1] Bruker Corporation. (8/10/26). "Press Release: Bruker Reports Second Quarter 2026 Financial Results". Billerica, MA....
• [2] Bruker Corporation. (8/10/26). "Press Release: Bruker Announces Majority Investment in Mimetas to Advance Human Physiology-Relevant Drug Discovery and Development". Leiden....
• [3] Bruker Corporation. (7/15/26). "Press Release: Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER Platform for Pathogenic Microorganisms in Blood". Bremen....
• [4] Bruker Corporation. (6/4/26). "Press Release: Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026". Washington, DC....
• [5] Bruker Corporation. (6/2/26). "Press Release: Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry". San Diego, CA....
• [6] Bruker Corporation. (5/26/26). "Press Release: Champalimaud Foundation’s Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRI". Billerica, MA....
• [7] Bruker Corporation. (5/26/26). "Press Release: Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – All to Enable Deep...
• [8] Bruker Corporation. (5/6/26). "Press Release: Bruker Reports First Quarter 2026 Financial Results". Billerica, MA....
• [9] Bruker Corporation. (4/17/26). "Press Release: Bruker Launches MyGenius PRO High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026". Munich....
• [10] Biognosys Group. (4/14/26). "Press Release: Biognosys Group Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson’s Disease Research Through the Development of Improved Biomarker Assays". Zürich....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2026. Made in Germany.